First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - NOBEL HEALTH CARE INVESTMENT & MANAGEMENT (UK) LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: NOBEL HEALTH CARE INVESTMENT & MANAGEMENT (UK) LIMITED, Flat 6 Hallam Court, Hallam Street, London, W1W 5HB. The legal status is a Private Limited Company and the current status at the registry of companies is Dissolved. The last filed accounts are dated 30 September 2020. The company was incorporated on 23 September 2016.

The accounts next due date is 30 June 2022. There are no mortgages.

The above was based on public record information as at 17 February 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 10391802
Date Incorporated: 23 September 2016
Date Latest Accounts: 30 September 2020
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: SCREEN CHINA LIVE LIMITED
Registered Number: 10391802
Annual Return: Unknown
Registered Office: Flat 6 Hallam Court, Hallam Street, London, W1W 5HB
SIC Code and Operations: 82990
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

NOBEL HEALTH CARE INVESTMENT & MANAGEMENT (UK) LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 27 February 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
15617095 NOBEL HEALTH TRAVEL LIMITED Active
11299689 NOBEL HEALTHCARE LTD Active
13104611 NOBEL HEALTHCARE LTD Active
14759236 NOBEL HOLDINGS LIMITED Active
12653196 NOBEL HOMES LTD Active

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd